Compare TEVA & UI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | UI |
|---|---|---|
| Founded | 1901 | 2003 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 33.8B |
| IPO Year | N/A | 2011 |
| Metric | TEVA | UI |
|---|---|---|
| Price | $28.43 | $577.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $27.00 | ★ $587.50 |
| AVG Volume (30 Days) | ★ 11.4M | 161.9K |
| Earning Date | 11-05-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | N/A | ★ 102.50 |
| EPS | 0.62 | ★ 13.07 |
| Revenue | ★ $16,776,000,000.00 | $2,756,974,000.00 |
| Revenue This Year | $4.74 | $15.29 |
| Revenue Next Year | $0.48 | $8.93 |
| P/E Ratio | $46.12 | ★ $44.22 |
| Revenue Growth | 0.02 | ★ 36.77 |
| 52 Week Low | $12.47 | $255.00 |
| 52 Week High | $28.68 | $803.60 |
| Indicator | TEVA | UI |
|---|---|---|
| Relative Strength Index (RSI) | 80.93 | 43.95 |
| Support Level | $24.01 | $540.17 |
| Resistance Level | $26.96 | $579.92 |
| Average True Range (ATR) | 0.68 | 25.54 |
| MACD | 0.19 | 5.44 |
| Stochastic Oscillator | 94.65 | 88.84 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Ubiquiti Inc is a seller of equipment and provides the related software platforms through web stores. The group develops technology platforms for high-capacity distributed Internet access, unified information technology, and consumer electronics for professional, home, and personal use. Its solutions are: high-performance networking technology for enterprises, service providers, and consumers. target the enterprise and service provider markets through a community of service providers, distributors, value-added resellers, webstores, systems integrators, and corporate IT professionals, which it refers to as the Ubiquiti Community. It targets consumers through digital marketing, including through webstores, retail chains, and, to a lesser extent, the Ubiquiti Community.